Cited 0 time in
Effect of Exendin-4 Expressed by Two-Step Transcription Amplification Plasmid System with Arginine-Grafted Bioreducible Polymer for Type 2 Diabetes
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Pyung-Hwan | - |
| dc.contributor.author | Lee, Minhyung | - |
| dc.contributor.author | Kim, Sung Wan | - |
| dc.date.accessioned | 2022-04-01T09:56:56Z | - |
| dc.date.available | 2022-04-01T09:56:56Z | - |
| dc.date.created | 2022-02-16 | - |
| dc.date.issued | 2012-05-16 | - |
| dc.identifier.issn | 1525-0016 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/136486 | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | NATURE PUBLISHING GROUP | - |
| dc.title | Effect of Exendin-4 Expressed by Two-Step Transcription Amplification Plasmid System with Arginine-Grafted Bioreducible Polymer for Type 2 Diabetes | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Lee, Minhyung | - |
| dc.identifier.wosid | 000303484600420 | - |
| dc.identifier.bibliographicCitation | 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), pp.S163 - S164 | - |
| dc.relation.isPartOf | 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) | - |
| dc.relation.isPartOf | MOLECULAR THERAPY | - |
| dc.citation.title | 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT) | - |
| dc.citation.startPage | S163 | - |
| dc.citation.endPage | S164 | - |
| dc.citation.conferencePlace | US | - |
| dc.citation.conferencePlace | Philadelphia, PA | - |
| dc.citation.conferenceDate | 2012-05-16 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
